Health Care & Life Sciences » Biotechnology | Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
91.5 M
Public Float
84.97 M
Inovio Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1
Market Cap
$296.06 M
Shares Outstanding
98.03 M
Public Float
89.22 M

Profile

Address
660 West Germantown Pike
Plymouth Meeting Pennsylvania 19462
United States
Employees -
Website http://www.inovio.com
Updated 07/08/2019
Inovio Pharmaceuticals, Inc. engages in the development of active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Financials

View All

Avtar S. Dhillon
Non-Executive Chairman
J. Joseph Kim
President, Chief Executive Officer & Director